|
業務類別
|
Biotechnology |
|
業務概覽
|
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy. |
| 公司地址
| 303A College Road, East Princeton, NJ, USA, 08540 |
| 電話號碼
| +1 800 208-3343 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pdsbiotech.com |
| 員工數量
| 21 |
| Dr. Kirk V. Shepard, M.D. |
Chief Medical Officer |
美元 426.35K |
30/03/2026 |
| Mr. Lars Boesgaard |
Chief Financial Officer and Principal Accounting Officer |
-- |
30/03/2026 |
| Mr. Stephan F. Toutain, M.B.A.,M.S. |
Chief Operations Officer |
美元 300.00K |
30/03/2026 |
| Dr. Frank Bedu-Addo, PhD |
Director, President and Chief Executive Officer |
美元 597.40K |
30/03/2026 |
| Mr. Spencer D. Brown |
Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer |
-- |
30/03/2026 |
| Dr. Gregory L. Conn, PhD |
Chief Scientific Officer |
-- |
30/03/2026 |
|
|
| Mr. Gregory G. Freitag, C.P.A.,J.D. |
Independent Director |
30/03/2026 |
| Dr. Ilian Petkov Iliev, PhD |
Director |
30/03/2026 |
| Dr. Frank Bedu-Addo, PhD |
Director, President and Chief Executive Officer |
30/03/2026 |
| Ms. Kamil Ali-Jackson, Esq. |
Independent Director |
30/03/2026 |
| Mr. Stephen C. Glover |
Chairman of the Board |
30/03/2026 |
| Dr. Otis W. Brawley,M.D. |
Independent Director |
30/03/2026 |
|
|
|
|
